UPAMOSTAT Drug Record

  • UPAMOSTAT chembl:CHEMBL4206119 Antineoplastic

    Alternate Names:

    UPAMOSTAT
    WX-671

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • UPAMOSTAT   PLAU

    Interaction Score: 4.76

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name Mesupron, WX-671
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial TTD

  • TdgClinicalTrial: WX-671

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class small molecule
    FDA Approval not approved

    Publications:

  • TTD: Upamostat

    • Version: 2020.06.01

    Alternate Names:
    D03KGH TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL4206119

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: